Español
PDFs by language
Our 24/7 cancer helpline provides information and answers for people dealing with cancer. We can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear.
Live Chat available weekdays, 7:00 am - 6:30 pm CT
Call us at 1-800-227-2345
Available any time of day or night
Our highly trained specialists are available 24/7 via phone and on weekdays can assist through online chat. We connect patients, caregivers, and family members with essential services and resources at every step of their cancer journey. Ask us how you can get involved and support the fight against cancer. Some of the topics we can assist with include:
For medical questions, we encourage you to review our information with your doctor.
Acute Myeloid Leukemia (AML) in Adults
Chemotherapy (chemo) is the use of anti-cancer drugs that are injected into a vein, under the skin, or into the cerebrospinal fluid (CSF), or that are taken by mouth to destroy or control cancer cells. Except when given into the CSF, these drugs enter the bloodstream and reach all areas of the body, making this treatment useful for cancers such as leukemia that spread throughout the body.
Chemotherapy is the main treatment for most people with acute myeloid leukemia (AML), although sometimes other treatments might be used as well.
Less intense chemo might be recommended for people with other serious health issues, but advanced age by itself is not a barrier to getting chemo.
Treatment of AML with chemo is usually in phases:
Remission induction (or just induction) is the first phase of treatment. It is short and intensive, typically lasting about a week. The goal is to clear the blood of leukemia cells (blasts) and to lower the number of blasts in the bone marrow to normal.
Consolidation chemo is given after a person has recovered from induction. It is meant to kill the small number of leukemia cells that are still around but can’t be seen (because there are so few of them). For consolidation, chemo is given in cycles, with each period of treatment followed by a rest period to allow the body time to recover. For some people, consolidation might include getting chemo as part of a stem cell transplant.
Maintenance (or post-consolidation) uses low doses of chemo (or other treatments) for months or years after consolidation is finished. This is often used to treat acute promyelocytic leukemia (APL), and it is sometimes used for other subtypes of AML as well.
Most chemo drugs used to treat AML are given into a vein (IV), usually through a central venous catheter, although some are injected under the skin or pills taken by mouth.
If there are signs that leukemia cells have reached the brain or spinal cord (which is not common with AML), chemo might also be given into the CSF (known as intrathecal chemo). This can be done with a thin tube (catheter) that is put in through a small hole in the skull (using a dome-shaped device that sits just under the scalp, called an Ommaya reservoir). Or chemo might be given during a lumbar puncture (spinal tap).
Most chemo regimens used to treat AML are intensive and can cause serious side effects, so treatment typically is given in the hospital.
The chemo drugs used most often to treat AML are a combination of:
Other chemo drugs that might be used to treat AML include:
For more on how chemo is used to treat AML, see Typical Treatment of Most Types of Acute Myeloid Leukemia (AML), Except APL.
Chemo drugs can affect some normal cells in the body, which can lead to side effects. The side effects will depend on the type and dose of drugs given and how long they are taken. Side effects can include:
Chemo drugs also affect the normal cells in bone marrow, which can lower blood cell counts. This can lead to:
Most side effects from chemo go away once treatment is finished. Low blood cell counts can last weeks, but then should return to normal.
There are often ways to manage side effects. For example, drugs can be given to help prevent or reduce nausea and vomiting. Be sure to ask about medicines to help lessen side effects, and let your doctor or nurse know if you have any side effects.
Low white blood cell counts: Some of the most serious side effects of chemo in people with AML are caused by not having enough normal white blood cells, which increases a person’s risk of infection.
If your white blood cell counts are very low during treatment, you can help lower your risk of infection by limiting your exposure to germs. During this time, your doctor or nurse may tell you to:
You may get antibiotics, either before you have signs of infection or at the earliest sign that an infection may be developing (such as a fever). You may also get drugs that help prevent viral and fungal infections.
To help lower the chance of infection, drugs known as growth factors, such as filgrastim (Neupogen and other names) and pegfilgrastim (Neulasta and other names) might be given to increase a person’s white blood cell counts after chemo. However, it’s not clear if they have an effect on treatment success.
Low platelet counts: If your platelet counts are low, you may be given drugs or platelet transfusions to help prevent bleeding.
Low red blood cell counts: Shortness of breath and feeling very tired, which can caused by low red blood cell counts (anemia), may be treated with drugs or with red blood cell transfusions.
Decisions about when a person can leave the hospital after getting chemo for AML are often influenced by their blood counts. Some people find it helpful to keep track of their counts. If you are interested in this, ask your doctor or nurse about your blood cell counts and what these numbers mean.
Fertility: Chemo may affect a person’s fertility, the ability to have children. If you think you might want to have children in the future, talk to your health care team about your family planning goals. They can tell you how the chemo might affect your fertility. You may want to talk to a fertility specialist before treatment begins.
Side effects of specific drugs: Certain chemo drugs have some specific possible side effects. For example:
Other organs that could be damaged by chemo drugs include the kidneys, liver, testicles, ovaries, and lungs. Doctors and nurses carefully monitor treatment to limit the risk of these side effects as much as possible.
If serious side effects occur, the chemo may have to be reduced or stopped, at least for a short time. Careful monitoring and adjustment of drug doses are important because some side effects can last a long time.
Tumor lysis syndrome: This side effect can occur in people who have large numbers of leukemia cells in their body, mainly during the induction phase of treatment. When chemo kills these cells, they break open and release their contents into the bloodstream. This can overwhelm kidneys, which aren’t able to get rid of all of these substances at once. Excess amounts of certain minerals can also affect the heart and nervous system.
This can be prevented by giving the person extra fluids during treatment and by giving certain drugs, such as bicarbonate, allopurinol, and rasburicase, which help rid the body of these substances.
For more general information about how chemotherapy is used to treat cancer, see Chemotherapy.
To learn about some of the side effects listed here and how to manage them, see Managing Cancer-related Side Effects.
Developed by the American Cancer Society medical and editorial content team with medical review and contribution by the American Society of Clinical Oncology (ASCO).
Appelbaum FR. Chapter 95: Acute leukemias in adults. In: Niederhuber JE, Armitage JO, Doroshow JH, Kastan MB, Tepper JE, eds. Abeloff’s Clinical Oncology. 6th ed. Philadelphia, Pa. Elsevier: 2020.
Kolitz JE. Acute myeloid leukemia in adults: Overview. UpToDate. 2024. Accessed at https://www.uptodate.com/contents/acute-myeloid-leukemia-in-adults-overview on December 2, 2024.
Larson RA. Acute myeloid leukemia: Management of medically unfit adults. UpToDate. 2024. Accessed at
https://www.uptodate.com/contents/acute-myeloid-leukemia-management-of-medically-unfit-adults on December 2, 2024.
Larson RA. Acute myeloid leukemia in younger adults: Post-remission therapy. UpToDate. 2024. Accessed at https://www.uptodate.com/contents/acute-myeloid-leukemia-in-younger-adults-post-remission-therapy on December 2, 2024.
Larson RA, Uy G. Acute myeloid leukemia: Induction therapy in medically fit adults. UpToDate. 2024. Accessed at
https://www.uptodate.com/contents/acute-myeloid-leukemia-induction-therapy-in-medically-fit-adults on December 2, 2024.
National Cancer Institute. Acute Myeloid Leukemia Treatment (PDQ)–Health Professional Version. 2024. Accessed at https://www.cancer.gov/types/leukemia/hp/adult-aml-treatment-pdq on December 2, 2024.
National Comprehensive Cancer Network. NCCN Practice Guidelines in Oncology (NCCN Guidelines): Acute Myeloid Leukemia. V.3.2024. Accessed at https://www.nccn.org on December 2, 2024.
Last Revised: March 4, 2025
American Cancer Society medical information is copyrighted material. For reprint requests, please see our Content Usage Policy.
Sign up to stay up-to-date with news, valuable information, and ways to get involved with the American Cancer Society.